Indoco Remedies informs about press release

26 Jul 2023 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indoco Remedies has informed that Competent Health Authority of Malta had inspected Company’s manufacturing facility for solid oral dosage form (Unit I) located at Baddi (‘Facility’), from April 20, 2023 to April 24, 2023. The Facility has received EU GMP certification from Competent Health Authority of Malta confirming that the Facility complies with the Good Manufacturing Practice requirements as referred in the EC Directive. The company has enclosed press release in this regard. 

The above information is a part of company’s filings submitted to BSE.


Indoco Remedies Share Price

329.00 4.55 (1.40%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.